Annual report pursuant to Section 13 and 15(d)

Restatement and Other Corrections of Previously Issued Consolidated Financial Statements - Statement of Cash Flows (Details)

v3.23.3
Restatement and Other Corrections of Previously Issued Consolidated Financial Statements - Statement of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jan. 29, 2023
Oct. 30, 2022
Jul. 31, 2022
May 01, 2022
Jul. 31, 2022
Oct. 30, 2022
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]                  
Net income $ 26,215 $ (7,362) $ 5,849 $ 1,786 $ 7,635 $ 273 $ 26,488 $ 47,488 $ 14,727
Adjustments to reconcile net income to net cash (used in) provided by operating activities:                  
Deferred income taxes       492 2,313 38 1,044 (9,721) 0
Changes in operating assets and liabilities:                  
Trade accounts receivable       2,134 (423) (6,810) (555) (4,034) 2,675
Merchandise inventories       (14,515) (37,199) (45,988) (11,135) (56,819) (14,017)
Prepaid expenses and other current assets       813 (16,510) (17,701) 3,087 968 (2,060)
Other assets       (26) (10) 7 (20,913) (1,047) 0
Accounts payable and accrued expenses       (11,768) (18,520) 1,208 (31,338) 38,187 19,584
Operating lease liabilities       (4,571) (10,064) (16,823) (22,263) (18,845) 0
Net Cash (Used in) Provided by Operating Activities       (23,327) (62,890) (68,386) (21,375) 32,648 40,521
Cash Flows from Investing Activities                  
Purchase of property and equipment       (4,450) (9,965) (18,115) (25,242) (14,615) (8,374)
Payments for patents and trademarks       (27) (160) (200) (307) (503) (678)
Net Cash Used in Investing Activities       (4,477) (10,125) (18,315) (25,549) (15,118) (9,052)
Cash Flows from Financing Activities                  
Net Cash Used in Financing Activities       (208) (1,725) (1,859) (1,935) (3,479) (1,667)
Net Change in Cash and Cash Equivalents       (28,012) (74,740) (88,560) (48,859) 14,051 29,802
Cash and Cash Equivalents - Beginning 3,832 17,652 64,380 92,392 92,392 92,392 92,392 78,341 48,539
Cash and Cash Equivalents - End 43,533 3,832 17,652 64,380 17,652 3,832 43,533 92,392 78,341
Non-cash investing activities:                  
Asset acquisitions not yet paid for at end of year       1,541 3,536 3,244 4,103 1,370 0
Previously Reported                  
Error Corrections and Prior Period Adjustments Restatement [Line Items]                  
Net income 27,644 (8,419) 7,122 1,895 9,017 598 28,242 45,900  
Adjustments to reconcile net income to net cash (used in) provided by operating activities:                  
Deferred income taxes       523 2,738 141 416 (9,836)  
Changes in operating assets and liabilities:                  
Trade accounts receivable       2,134 (423) (6,810) (921)    
Merchandise inventories       (14,515) (38,133) (45,988) (11,470)    
Prepaid expenses and other current assets       270 (17,916) (20,547) 890 (2,459)  
Other assets       0 0 0 (21,459) 0  
Accounts payable and accrued expenses       (10,359) (16,024) 3,281 (33,002) 39,195  
Operating lease liabilities       (4,062) (8,501) (13,227) (18,281) (14,400)  
Net Cash (Used in) Provided by Operating Activities       (21,786) (59,354) (65,142) (21,375) 34,018  
Cash Flows from Investing Activities                  
Purchase of property and equipment       (5,893) (13,461) (21,292)   (15,887)  
Payments for patents and trademarks       (125) (200) (267)   (601)  
Net Cash Used in Investing Activities       (6,018) (13,661) (21,559) (25,549) (16,488)  
Cash Flows from Financing Activities                  
Net Cash Used in Financing Activities       (208) (1,725) (1,859) (1,935) (3,479)  
Net Change in Cash and Cash Equivalents       (28,012) (74,740) (88,560) (48,859) 14,051  
Cash and Cash Equivalents - Beginning 3,832 17,652 64,380 92,392 92,392 92,392 92,392 78,341  
Cash and Cash Equivalents - End 43,533 3,832 17,652 64,380 17,652 3,832 43,533 92,392 78,341
Non-cash investing activities:                  
Asset acquisitions not yet paid for at end of year       0 0 0   0  
Revision of Prior Period, Error Correction, Adjustment                  
Error Corrections and Prior Period Adjustments Restatement [Line Items]                  
Net income   1,057 (1,273) (109) (1,382) (325) (1,754) 1,588  
Adjustments to reconcile net income to net cash (used in) provided by operating activities:                  
Deferred income taxes       (31) (425) (103) 628 115  
Changes in operating assets and liabilities:                  
Trade accounts receivable       0 0 0 366    
Merchandise inventories       0 934 0 335    
Prepaid expenses and other current assets       543 1,406 2,846 2,197 3,427  
Other assets       (26) (10) 7 546 (1,047)  
Accounts payable and accrued expenses       (1,409) (2,496) (2,073) 1,664 (1,008)  
Operating lease liabilities       (509) (1,563) (3,596) (3,982) (4,445)  
Net Cash (Used in) Provided by Operating Activities       (1,541) (3,536) (3,244) 0 (1,370)  
Cash Flows from Investing Activities                  
Purchase of property and equipment       1,443 3,496 3,177   1,272  
Payments for patents and trademarks       98 40 67   98  
Net Cash Used in Investing Activities       1,541 3,536 3,244 0 1,370  
Cash Flows from Financing Activities                  
Net Cash Used in Financing Activities       0 0 0 0 0  
Net Change in Cash and Cash Equivalents       0 0 0 0 0  
Cash and Cash Equivalents - Beginning 0 0 0 0 0 0 0 0  
Cash and Cash Equivalents - End $ 0 $ 0 $ 0 0 0 0 $ 0 0 $ 0
Non-cash investing activities:                  
Asset acquisitions not yet paid for at end of year       $ 1,541 $ 3,536 $ 3,244   $ 1,370